Apria, Inc. (APR): Price and Financial Metrics
APR Price/Volume Stats
| Current price | $37.50 | 52-week high | $40.00 |
| Prev. close | $37.49 | 52-week low | $22.36 |
| Day low | $37.49 | Volume | 585,400 |
| Day high | $37.51 | Avg. volume | 682,285 |
| 50-day MA | $37.33 | Dividend yield | N/A |
| 200-day MA | $33.53 | Market Cap | 1.34B |
APR Stock Price Chart Interactive Chart >
Apria, Inc. (APR) Company Bio
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also offers a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Latest APR News From Around the Web
Below are the latest news stories about Apria Inc that investors may wish to consider to help them evaluate APR as an investment opportunity.
Apria Announces Expiration of Hart-Scott-Rodino Waiting PeriodINDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the |
Owens & Minor: Not A Minor DealOwens & Minor (OMI) has come to life during the pandemic. In October 2020, I concluded that shares looked a lot healthier, as shares had five-folded on the back of the pandemic. Stagnating sales, non-inspiring margins, and a debt-loaded balance sheet made investors very cautious, as the pandemic came at... |
Is Apria (APR) Stock Outpacing Its Medical Peers This Year?Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year. |
Company News for Jan 11, 2022Companies in The News Are: CMC,AZZ,ZNGA,TTWO,APR,OMI |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back, trader! |
APR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 26.69% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...